.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
AstraZeneca
Covington
Cerilliant
Farmers Insurance
QuintilesIMS
Baxter
McKinsey
Citi
Medtronic

Generated: November 18, 2017

DrugPatentWatch Database Preview

Prednisolone sodium phosphate - Generic Drug Details

« Back to Dashboard

What are the generic sources for prednisolone sodium phosphate and what is the scope of prednisolone sodium phosphate freedom to operate?

Prednisolone sodium phosphate
is the generic ingredient in thirteen branded drugs marketed by Vintage, Pharm Assoc, Pharmafair, Vintage Pharms, Watson Labs, Concordia Pharms Inc, Merck, Schering, Alcon Pharms Ltd, Amneal Pharms, Medicis Pharms, Novartis, Seton Pharm, Akorn, Edenbridge Pharms, Bausch And Lomb, Sola Barnes Hind, Mylan Pharms Inc, We Pharms, Nesher Pharms, Hi Tech Pharma, Chartwell Rx, Wockhardt, Mission Pharma, and Sandoz Inc, and is included in forty-one NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Prednisolone sodium phosphate has nine patent family members in seven countries.

There are eighty-six drug master file entries for prednisolone sodium phosphate. Twenty-three suppliers are listed for this compound.

Pharmacology for prednisolone sodium phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn
PREDNISOLONE SODIUM PHOSPHATE
prednisolone sodium phosphate
SOLUTION/DROPS;OPHTHALMIC083358-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Concordia Pharms Inc
ORAPRED ODT
prednisolone sodium phosphate
TABLET, ORALLY DISINTEGRATING;ORAL021959-002Jun 1, 2006ABRXYesNo► Subscribe► SubscribeY ► Subscribe
Akorn
PREDNISOLONE SODIUM PHOSPHATE
prednisolone sodium phosphate
SOLUTION/DROPS;OPHTHALMIC083358-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Assoc
PREDNISOLONE SODIUM PHOSPHATE
prednisolone sodium phosphate
SOLUTION;ORAL078988-001Jun 9, 2008AARXNoYes► Subscribe► Subscribe► Subscribe
Bausch And Lomb
PREDNISOLONE SODIUM PHOSPHATE
prednisolone sodium phosphate
SOLUTION/DROPS;OPHTHALMIC040065-001Jul 29, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Sola Barnes Hind
PREDNISOLONE SODIUM PHOSPHATE
prednisolone sodium phosphate
SOLUTION/DROPS;OPHTHALMIC084168-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Assoc
PREDNISOLONE SODIUM PHOSPHATE
prednisolone sodium phosphate
SOLUTION;ORAL076913-001Apr 25, 2005AARXNoNo► Subscribe► Subscribe► Subscribe
Concordia Pharms Inc
ORAPRED
prednisolone sodium phosphate
SOLUTION;ORAL075117-001Dec 14, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Rx
PREDNISOLONE SODIUM PHOSPHATE
prednisolone sodium phosphate
SOLUTION;ORAL075988-001May 25, 2004AARXNoNo► Subscribe► Subscribe► Subscribe
Pharmafair
PREDAIR
prednisolone sodium phosphate
SOLUTION/DROPS;OPHTHALMIC088415-001Feb 29, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: prednisolone sodium phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Seton Pharm
PEDIAPRED
prednisolone sodium phosphate
SOLUTION;ORAL019157-001May 28, 1986► Subscribe► Subscribe
Concordia Pharms Inc
ORAPRED ODT
prednisolone sodium phosphate
TABLET, ORALLY DISINTEGRATING;ORAL021959-003Jun 1, 2006► Subscribe► Subscribe
Concordia Pharms Inc
ORAPRED ODT
prednisolone sodium phosphate
TABLET, ORALLY DISINTEGRATING;ORAL021959-002Jun 1, 2006► Subscribe► Subscribe
Concordia Pharms Inc
ORAPRED ODT
prednisolone sodium phosphate
TABLET, ORALLY DISINTEGRATING;ORAL021959-001Jun 1, 2006► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: prednisolone sodium phosphate

Country Document Number Estimated Expiration
Japan2002530322► Subscribe
Hong Kong1146901► Subscribe
Australia753476► Subscribe
Spain2601855► Subscribe
European Patent Office2260836► Subscribe
World Intellectual Property Organization (WIPO)0030617► Subscribe
Australia1922000► Subscribe
European Patent Office1133282► Subscribe
Canada2351720► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Julphar
Cipla
Express Scripts
Fuji
Healthtrust
Deloitte
UBS
Argus Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot